“The statement would be out out by the PR agency
Post# of 146739
NP engineers nearly every PR and that’s why they read like an OTC energy drink company. The PR company adds the punctuation.
Below is an example of how a bland PR, without the primary outcome and statistical significance, reads (and flops):
https://www.cytodyn.com/newsroom/press-releas...d-19-trial
Aaaand here’s the rerelease of the above PR because the original PR wasn’t bad enough:
https://www.cytodyn.com/newsroom/press-releas...ns-phase-2
Point: The first post-unblinding PR for the S/C trial needs to be written by a BP PR expert, contain the mortality reduction, p value, safety and secondary endpoints (if stay sig). Nothing less.